Does the addition of integrated cognitive behaviour therapy and motivational interviewing improve the outcomes of standard care for young people with comorbid depression and substance misuse?

Medical Journal of Australia

Volumn 195, Issue 3 SUPPL., 2011, Pages

  Hides, Leanne M ^a   Elkins, Kathryn S ^b   Scaffidi, Antonietta ^b   Cotton, Sue M ^b   Carroll, Steve ^b   Lubman, Daniel I ^b,c  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c EASTERN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; OPIATE; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADOLESCENT; ADULT; ALCOHOLISM; ARTICLE; AUSTRALIA; CANNABIS ADDICTION; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT CARE; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SUBSTANCE ABUSE;

EID: 79961083260     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2011.tb03263.x     Document Type: Article

References (32)

1. Lubman DI, Allen NB, Rogers N, et al. The impact of co-occurring mood and anxiety disorders among substance-abusing youth. J Affect Disord 2007; 103: 105-112.
2. Grella CE, Hser Y-I, Joshi V, Rounds-Bryant J. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 2001; 189: 384-392.
3. Sullivan LE, Fiellin DA, O'Connor P. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med 2005; 118: 330-341.
4. Hides L, Elkins K, Catania LS, et al. Feasibility and outcomes of an innovative cognitivebehavioural skill training programme for cooccurring disorders in the youth alcohol and other drug (AOD) sector. Drug Alcohol Rev 2007; 26: 513-519.
5. Hides L, Lubman DI, Elkins K, et al. Feasibility and acceptability of a mental health screening tool and training programme in the youth alcohol and other drug (AOD) sector. Drug Alcohol Rev 2007; 26: 509-515.
6. Deas D, Randall CL, Roberts JS, Anton RF. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Hum Psychopharmacol 2000; 15: 461-469.
7. Moak DH, Anton RF, Latham PK, et al. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol 2003; 23: 553-562.
8. Riggs PD, Mikulich-Gilbertson SK, Davies RD, et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med 2007; 161: 1026-1034.
9. Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction 2009; 104: 378-388.
10. Baker AL, Kavanagh DJ, Kay-Lambkin FJ, et al. Randomized controlled trial of cognitivebehavioural therapy for coexisting depression and alcohol problems: short-term outcome. Addiction 2010; 105: 87-99.
11. Hides L, Lubman D, Carroll S, et al. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people: a pilot study. J Affect Disord 2010; 121: 169-174.
12. National Health and Medical Research Council. Australian alcohol guidelines for low-risk drinking. Canberra: NHMRC, 2007.
13. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003; 60: 184-189.
14. National Health and Medical Research Council. Australian alcohol guidelines: health risks and benefits. Canberra: NHMRC, 2001.
15. Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health 2001; 25: 494-497.
16. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV-TR axis I disorders, research version, patient edition. New York: Biometrics Research, New York State Psychiatric Institute, 2001.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: APA, 2000.
18. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
19. Dozois DJ. The psychometric characteristics of the Hamilton Depression Inventory. J Pers Assess 2003; 80: 31-40.
20. Van Dam NT, Earleywine M. Validation of the Center for Epidemiologic Studies Depression Scale - Revised (CESD-R): pragmatic depression assessment in the general population. Psychiatry Res 2011; 186: 128-132.
21. Sobell LC, Sobell MB. Timeline Followback user's guide: a calendar method for assessing alcohol and drug use. Toronto: Addiction Research Foundation, 1996.
22. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption - II. Addiction 1993; 88: 791-804.
23. Gossop M, Darke S, Griffiths P, Hando J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607-614.
24. Dennis ML, Funk R, Godley SH, et al. Crossvalidation of the alcohol and cannabis use measures in the Global Appraisal of Individual Needs (GAIN) and Timeline Followback (TLFB; Form 90) among adolescents in substance abuse treatment. Addiction 2004; 99 Suppl 2: 120-128.
25. Fairlie AM, Sindelar HA, Eaton CA, Spirito A. Utility of the AUDIT for screening adolescents for problematic alcohol use in the emergency department. Int J Adolesc Med Health 2006; 18: 115-122.
26. Martin G, Copeland J, Gates P, Gilmour S. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. Drug Alcohol Depend 2006; 83: 90-93.
27. Heather N, Rollnick S. Readiness to Change Questionnaire: user's manual. Newcastle, UK: Centre for Alcohol & Drug Studies, Newcastle City Health NHS Trust, and Centre for Clinical Psychology and Healthcare Research, University of Northumbria at Newcastle, 2000.
28. Hollan SD, Kendall PC. Cognitive self-statements in depression: development of an Automatic Thoughts Questionnaire. Cognit Ther Res 1980; 4: 383-395.
29. Mueser KT, Nishith P, Tracy JI, et al. Expectations and motives for substance use in schizophrenia. Schizophr Bull 1995; 21: 367-378.
30. Endler NS, Parker JD. Assessment of multidimensional coping: task, emotion, and avoidance strategies. Psychol Assess 1994; 6: 50-60.
31. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann 1988; 11: 51-62.
32. Hides L, Lubman DI, Kay-Lambkin FJ, Baker A. Young people with co-existing mental health and drug and alcohol problems. In: Baker A, Velleman R, editors. Clinical handbook of coexisting mental health and drug and alcohol problems. London: Routledge, 2007: 132-158.